SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on August 22, 2023. The filing serves as a Regulation FD disclosure regarding a press release announcing new software features for the company's PURE EP™ Platform. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a product announcement rather than financial performance data.
Material Changes
The material event reported is the release of new software features for the PURE EP™ Platform. No financial comparisons to prior periods are included in this document.
Guidance, Outlook, and Risks
- Management Commentary: The company issued a press release (Exhibit 99.1) detailing the new software features.
- Forward-Looking Statements: The Company explicitly states it undertakes no obligation to update, supplement, or amend the materials attached to this filing.
- Legal Disclaimer: Information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section. It is not intended to constitute a determination that the information is material or required by Regulation FD.
Key Facts for Investor Verification
- Verify the specific details of the new software features for the PURE EP™ Platform in the attached press release (Exhibit 99.1), as the 8-K body only references the announcement.
- Confirm that this filing contains no audited financial data or updated guidance.
- Note the explicit disclaimer that the company is not obligated to update the information provided in this report.